Article
Identification of immune subtypes and prognosis of hepatocellular carcinoma based on immune checkpoint gene expression profile
26 Feb 2020
Abstract excerpt
The significant response of immunotherapy is currently limited to a small number of patients, which has a high degree of selectivity. Therefore, distinguishing the immune subtypes of the tumor is necessary for patients who may benefit from immune checkpoint therapy. Clinical data and RNA expression data from The Cancer Genome Atlas (TCGA) and GENE EXPRESSION OMNIBUS (GEO) databases were used to study the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
